Open clinical trial on the sigma ligand panamesine in patients with schizophrenia

  • R.-M. Frieboes, Harald Murck, Klaus Wiedemann, Florian Holsboer, Axel Steiger
  • Psychopharmacology, July 1997, Springer Science + Business Media
  • DOI: 10.1007/s002130050323

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Axel Steiger